Physicians

Department / Division
Medicine / Medicine - Oncology

Address
3100 Tower Boulevard, Suite 600
Durham, NC 27707

Appointment Telephone
919-419-5005

Office Telephone
919-419-5005

Fax Telephone
919-493-3234

Training

• MD, Northwestern University Feinberg School of Medicine (Illinois), 1982

Residency

• General Internal Medicine, Northwestern Memorial Hospital (Illinois), 1982-1985

Fellowship

• Medical Oncology, University of Wisconsin Hospital, Madison, 1985-1987
• Hematology/Oncology, University of Texas Health Science Center at San Antonio, 1987-1988

Clinical Interests
Breast cancer, adjuvant, metastatic and preventive treatment; general oncology

Industry Relationships and Collaborations (What's this?)

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

• The France Foundation

Representative Publications
Havlin K. A phase I/phase II trial of granulocyte colony-stimulating factor as bone marrow support in patients treated with vinorelbine (Navelbine): study design and goals. Semin in Oncol 22:2 (suppl 5) 38-40, 1995. (1995)

Brown T, Havlin KA, Weiss G, Cagola J, Koeller JM, Kuhn JG, Rizzo J, Craig J, Von Hoff DD. A phase I trial of taxol given by a 6 hour intravenous infusion. J Clin Oncolo 9:1261-1267, 1991. (1991)

Havlin KA, Kuhn JG, Craig JB, Boldt DH, Weiss GR, Koeller JM, Harmon GS, Scwartz R, Clark GN, Von Hoff DD. Phase I clinical and pharmacokinetic trial of flavone acetic acid. J Natl Cancer Inst 83:124-128, 1991. (1991)

Havlin KA, Kuhn JG, Craig JB, Weiss GR, Koeller JM, Turner JN, Luther JS, Clark G, Bair KW, Wargin W, Purvis J, Lucas VS, Tuttle RL, Von Hoff DD. Phase I evaluation of 773U82 HCL, a member of a new class of DNA intercalators. Anti-Cancer Drugs 2:357-363, 1991. (1991)

Havlin KA, Kuhn JG, Myers JW, Ozols R, Mattox D, Clark G, Von Hoff DD. High-dose cis-platinum for locally advanced or metastatic head and neck cancer - A phase II pilot study. Cancer 63:423-427, 1989. (1989)